LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: The Unexpected Benefit of TCR Cross-Reactivity in Cancer Immunotherapy.

    Bieberich, Florian / Reddy, Sai T

    Cancer research

    2023  Volume 83, Issue 19, Page(s) 3168–3169

    Abstract: The ability of T-cell receptors (TCR) to recognize tumor-associated antigens (TAA) is a key driver of adoptive transfer of tumor-infiltrating lymphocyte (TIL) T cells, which can be a highly effective cancer immunotherapy. While it is common knowledge ... ...

    Abstract The ability of T-cell receptors (TCR) to recognize tumor-associated antigens (TAA) is a key driver of adoptive transfer of tumor-infiltrating lymphocyte (TIL) T cells, which can be a highly effective cancer immunotherapy. While it is common knowledge that TCRs are cross-reactive and can bind multiple different peptide antigens, this is typically considered an unattractive feature and limitation for TCR-based therapies. In a recent publication in Cell, Dolton and colleagues discover that certain TCRs, isolated from TILs used for successful treatment of melanoma, possess beneficial cross-reactivity by recognizing multiple TAA. Moreover, they elucidate the cumulative value of TCR cross-reactivity on cancer cell eradication and its prospective advantages for targeted cancer immunotherapies.
    MeSH term(s) Humans ; Prospective Studies ; Receptors, Antigen, T-Cell ; T-Lymphocytes ; Lymphocytes, Tumor-Infiltrating ; Antigens, Neoplasm ; Immunotherapy ; Melanoma/therapy ; Immunotherapy, Adoptive
    Chemical Substances Receptors, Antigen, T-Cell ; Antigens, Neoplasm
    Language English
    Publishing date 2023-09-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-23-2594
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing.

    Castellanos-Rueda, Rocío / Di Roberto, Raphaël B / Bieberich, Florian / Schlatter, Fabrice S / Palianina, Darya / Nguyen, Oanh T P / Kapetanovic, Edo / Läubli, Heinz / Hierlemann, Andreas / Khanna, Nina / Reddy, Sai T

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 6555

    Abstract: Chimeric antigen receptors (CARs) consist of an antigen-binding region fused to intracellular signaling domains, enabling customized T cell responses against targets. Despite their major role in T cell activation, effector function and persistence, only ... ...

    Abstract Chimeric antigen receptors (CARs) consist of an antigen-binding region fused to intracellular signaling domains, enabling customized T cell responses against targets. Despite their major role in T cell activation, effector function and persistence, only a small set of immune signaling domains have been explored. Here we present speedingCARs, an integrated method for engineering CAR T cells via signaling domain shuffling and pooled functional screening. Leveraging the inherent modularity of natural signaling domains, we generate a library of 180 unique CAR variants genomically integrated into primary human T cells by CRISPR-Cas9. In vitro tumor cell co-culture, followed by single-cell RNA sequencing (scRNA-seq) and single-cell CAR sequencing (scCAR-seq), enables high-throughput screening for identifying several variants with tumor killing properties and T cell phenotypes markedly different from standard CARs. Mapping of the CAR scRNA-seq data onto that of tumor infiltrating lymphocytes further helps guide the selection of variants. These results thus help expand the CAR signaling domain combination space, and supports speedingCARs as a tool for the engineering of CARs for potential therapeutic development.
    MeSH term(s) Humans ; Receptors, Chimeric Antigen/genetics ; T-Lymphocytes ; Signal Transduction ; Lymphocyte Activation ; Neoplasms ; Receptors, Antigen, T-Cell/genetics
    Chemical Substances Receptors, Chimeric Antigen ; Receptors, Antigen, T-Cell
    Language English
    Publishing date 2022-11-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-34141-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity.

    Vazquez-Lombardi, Rodrigo / Jung, Johanna S / Schlatter, Fabrice S / Mei, Anna / Mantuano, Natalia Rodrigues / Bieberich, Florian / Hong, Kai-Lin / Kucharczyk, Jakub / Kapetanovic, Edo / Aznauryan, Erik / Weber, Cédric R / Zippelius, Alfred / Läubli, Heinz / Reddy, Sai T

    Immunity

    2022  Volume 55, Issue 10, Page(s) 1953–1966.e10

    Abstract: A major challenge in adoptive T cell immunotherapy is the discovery of natural T cell receptors (TCRs) with high activity and specificity to tumor antigens. Engineering synthetic TCRs for increased tumor antigen recognition is complicated by the risk of ... ...

    Abstract A major challenge in adoptive T cell immunotherapy is the discovery of natural T cell receptors (TCRs) with high activity and specificity to tumor antigens. Engineering synthetic TCRs for increased tumor antigen recognition is complicated by the risk of introducing cross-reactivity and by the poor correlation that can exist between binding affinity and activity of TCRs in response to antigen (peptide-MHC). Here, we developed TCR-Engine, a method combining genome editing, computational design, and deep sequencing to engineer the functional activity and specificity of TCRs on the surface of a human T cell line at high throughput. We applied TCR-Engine to successfully engineer synthetic TCRs for increased potency and specificity to a clinically relevant tumor-associated antigen (MAGE-A3) and validated their translational potential through multiple in vitro and in vivo assessments of safety and efficacy. Thus, TCR-Engine represents a valuable technology for engineering of safe and potent synthetic TCRs for immunotherapy applications.
    MeSH term(s) Antigens, Neoplasm ; Humans ; Immunotherapy ; Immunotherapy, Adoptive ; Peptides ; Receptors, Antigen, T-Cell
    Chemical Substances Antigens, Neoplasm ; Peptides ; Receptors, Antigen, T-Cell
    Language English
    Publishing date 2022-09-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1217235-2
    ISSN 1097-4180 ; 1074-7613
    ISSN (online) 1097-4180
    ISSN 1074-7613
    DOI 10.1016/j.immuni.2022.09.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: speedingCARs

    Rocío Castellanos-Rueda / Raphaël B. Di Roberto / Florian Bieberich / Fabrice S. Schlatter / Darya Palianina / Oanh T. P. Nguyen / Edo Kapetanovic / Heinz Läubli / Andreas Hierlemann / Nina Khanna / Sai T. Reddy

    Nature Communications, Vol 13, Iss 1, Pp 1-

    accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing

    2022  Volume 16

    Abstract: Chimeric antigen receptors (CAR) are a promising option for cell-based immunotherapy for cancer and other immune diseases. Here the authors develop speedingCARs, an integrated CAR design and screening platform based on modular signaling domain shuffling ... ...

    Abstract Chimeric antigen receptors (CAR) are a promising option for cell-based immunotherapy for cancer and other immune diseases. Here the authors develop speedingCARs, an integrated CAR design and screening platform based on modular signaling domain shuffling and single cell transcriptomic analyses, and test its potential for identifying and validating novel CAR designs.
    Keywords Science ; Q
    Language English
    Publishing date 2022-11-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Platypus: an open-access software for integrating lymphocyte single-cell immune repertoires with transcriptomes.

    Yermanos, Alexander / Agrafiotis, Andreas / Kuhn, Raphael / Robbiani, Damiano / Yates, Josephine / Papadopoulou, Chrysa / Han, Jiami / Sandu, Ioana / Weber, Cédric / Bieberich, Florian / Vazquez-Lombardi, Rodrigo / Dounas, Andreas / Neumeier, Daniel / Oxenius, Annette / Reddy, Sai T

    NAR genomics and bioinformatics

    2021  Volume 3, Issue 2, Page(s) lqab023

    Abstract: High-throughput single-cell sequencing (scSeq) technologies are revolutionizing the ability to molecularly profile B and T lymphocytes by offering the opportunity to simultaneously obtain information on adaptive immune receptor repertoires (VDJ ... ...

    Abstract High-throughput single-cell sequencing (scSeq) technologies are revolutionizing the ability to molecularly profile B and T lymphocytes by offering the opportunity to simultaneously obtain information on adaptive immune receptor repertoires (VDJ repertoires) and transcriptomes. An integrated quantification of immune repertoire parameters, such as germline gene usage, clonal expansion, somatic hypermutation and transcriptional states opens up new possibilities for the high-resolution analysis of lymphocytes and the inference of antigen-specificity. While multiple tools now exist to investigate gene expression profiles from scSeq of transcriptomes, there is a lack of software dedicated to single-cell immune repertoires. Here, we present Platypus, an open-source software platform providing a user-friendly interface to investigate B-cell receptor and T-cell receptor repertoires from scSeq experiments. Platypus provides a framework to automate and ease the analysis of single-cell immune repertoires while also incorporating transcriptional information involving unsupervised clustering, gene expression and gene ontology. To showcase the capabilities of Platypus, we use it to analyze and visualize single-cell immune repertoires and transcriptomes from B and T cells from convalescent COVID-19 patients, revealing unique insight into the repertoire features and transcriptional profiles of clonally expanded lymphocytes. Platypus will expedite progress by facilitating the analysis of single-cell immune repertoire and transcriptome sequencing.
    Language English
    Publishing date 2021-04-14
    Publishing country England
    Document type Journal Article
    ISSN 2631-9268
    ISSN (online) 2631-9268
    DOI 10.1093/nargab/lqab023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.

    Bieberich, Florian / Vazquez-Lombardi, Rodrigo / Yermanos, Alexander / Ehling, Roy A / Mason, Derek M / Wagner, Bastian / Kapetanovic, Edo / Di Roberto, Raphael Brisset / Weber, Cédric R / Savic, Miodrag / Rudolf, Fabian / Reddy, Sai T

    Frontiers in immunology

    2021  Volume 12, Page(s) 701085

    Abstract: COVID-19 disease outcome is highly dependent on adaptive immunity from T and B lymphocytes, which play a critical role in the control, clearance and long-term protection against SARS-CoV-2. To date, there is limited knowledge on the composition of the T ... ...

    Abstract COVID-19 disease outcome is highly dependent on adaptive immunity from T and B lymphocytes, which play a critical role in the control, clearance and long-term protection against SARS-CoV-2. To date, there is limited knowledge on the composition of the T and B cell immune receptor repertoires [T cell receptors (TCRs) and B cell receptors (BCRs)] and transcriptomes in convalescent COVID-19 patients of different age groups. Here, we utilize single-cell sequencing (scSeq) of lymphocyte immune repertoires and transcriptomes to quantitatively profile the adaptive immune response in COVID-19 patients of varying age. We discovered highly expanded T and B cells in multiple patients, with the most expanded clonotypes coming from the effector CD8
    MeSH term(s) Adaptive Immunity ; Adult ; Aged ; Aging/immunology ; B-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; COVID-19/immunology ; Cells, Cultured ; Convalescence ; Female ; Humans ; Male ; Middle Aged ; Receptors, Antigen, B-Cell/genetics ; Receptors, Antigen, T-Cell/genetics ; SARS-CoV-2/physiology ; Single-Cell Analysis ; Transcriptome ; Young Adult
    Chemical Substances Receptors, Antigen, B-Cell ; Receptors, Antigen, T-Cell
    Language English
    Publishing date 2021-07-12
    Publishing country Switzerland
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.701085
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Locus-specific expression of transposable elements in single cells with CELLO-seq.

    Berrens, Rebecca V / Yang, Andrian / Laumer, Christopher E / Lun, Aaron T L / Bieberich, Florian / Law, Cheuk-Ting / Lan, Guocheng / Imaz, Maria / Bowness, Joseph S / Brockdorff, Neil / Gaffney, Daniel J / Marioni, John C

    Nature biotechnology

    2021  Volume 40, Issue 4, Page(s) 546–554

    Abstract: Transposable elements (TEs) regulate diverse biological processes, from early development to cancer. Expression of young TEs is difficult to measure with next-generation, single-cell sequencing technologies because their highly repetitive nature means ... ...

    Abstract Transposable elements (TEs) regulate diverse biological processes, from early development to cancer. Expression of young TEs is difficult to measure with next-generation, single-cell sequencing technologies because their highly repetitive nature means that short complementary DNA reads cannot be unambiguously mapped to a specific locus. Single CELl LOng-read RNA-sequencing (CELLO-seq) combines long-read single cell RNA-sequencing with computational analyses to measure TE expression at unique loci. We used CELLO-seq to assess the widespread expression of TEs in two-cell mouse blastomeres as well as in human induced pluripotent stem cells. Across both species, old and young TEs showed evidence of locus-specific expression with simulations demonstrating that only a small number of very young elements in the mouse could not be mapped back to the reference with high confidence. Exploring the relationship between the expression of individual elements and putative regulators revealed large heterogeneity, with TEs within a class showing different patterns of correlation and suggesting distinct regulatory mechanisms.
    MeSH term(s) Animals ; DNA Transposable Elements/genetics ; Humans ; Induced Pluripotent Stem Cells ; Mice ; RNA
    Chemical Substances DNA Transposable Elements ; RNA (63231-63-0)
    Language English
    Publishing date 2021-11-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1311932-1
    ISSN 1546-1696 ; 1087-0156
    ISSN (online) 1546-1696
    ISSN 1087-0156
    DOI 10.1038/s41587-021-01093-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A single-cell atlas of lymphocyte adaptive immune repertoires and transcriptomes reveals age-related differences in convalescent COVID-19 patients

    Bieberich, Florian / Vazquez-Lombardi, Rodrigo / Yermanos, Alexander / Ehling, Roy A / Wagner, Bastian / Kapetanovic, Edo / Di Roberto, Raphael Brisset / Savic, Miodrag / Rudolf, Fabian / Reddy, Sai T

    bioRxiv

    Abstract: COVID-19 disease outcome is highly dependent on adaptive immunity from T and B lymphocytes, which play a critical role in the control, clearance and long-term protection against SARS-CoV-2. To date, there is limited knowledge on the composition of the T ... ...

    Abstract COVID-19 disease outcome is highly dependent on adaptive immunity from T and B lymphocytes, which play a critical role in the control, clearance and long-term protection against SARS-CoV-2. To date, there is limited knowledge on the composition of the T and B cell immune receptor repertoires [T cell receptors (TCRs) and B cell receptors (BCRs)] and transcriptomes in convalescent COVID-19 patients of different age groups. Here, we utilize single-cell sequencing (scSeq) of lymphocyte immune repertoires and transcriptomes to quantitatively profile the adaptive immune response in COVID-19 patients of varying age. We discovered highly expanded T and B cells in multiple patients, with the most expanded clonotypes coming from the effector CD8+ T cell population. Highly expanded CD8+ and CD4+ T cell clones show elevated markers of cytotoxicity (CD8: PRF1, GZMH, GNLY; CD4: GZMA), whereas clonally expanded B cells show markers of transition into the plasma cell state and activation across patients. By comparing young and old convalescent COVID-19 patients (mean ages = 31 and 66.8 years, respectively), we found that clonally expanded B cells in young patients were predominantly of the IgA isotype and their BCRs had incurred higher levels of somatic hypermutation than elderly patients. In conclusion, our scSeq analysis defines the adaptive immune repertoire and transcriptome in convalescent COVID-19 patients and shows important age-related differences implicated in immunity against SARS-CoV-2.
    Keywords covid19
    Language English
    Publishing date 2021-02-12
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2021.02.12.430907
    Database COVID19

    Kategorien

  9. Article ; Online: A single-cell atlas of lymphocyte adaptive immune repertoires and transcriptomes reveals age-related differences in convalescent COVID-19 patients

    Bieberich, Florian / Vazquez-Lombardi, Rodrigo / Yermanos, Alexander / Ehling, Roy A / Mason, Derek M / Wagner, Bastian / Kapetanovic, Edo / Di Roberto, Raphael Brisset / Weber, Cedric R / Savic, Miodrag / Rudolf, Fabian / Reddy, Sai T

    bioRxiv

    Abstract: COVID-19 disease outcome is highly dependent on adaptive immunity from T and B lymphocytes, which play a critical role in the control, clearance and long-term protection against SARS-CoV-2. To date, there is limited knowledge on the composition of the T ... ...

    Abstract COVID-19 disease outcome is highly dependent on adaptive immunity from T and B lymphocytes, which play a critical role in the control, clearance and long-term protection against SARS-CoV-2. To date, there is limited knowledge on the composition of the T and B cell immune receptor repertoires [T cell receptors (TCRs) and B cell receptors (BCRs)] and transcriptomes in convalescent COVID-19 patients of different age groups. Here, we utilize single-cell sequencing (scSeq) of lymphocyte immune repertoires and transcriptomes to quantitatively profile the adaptive immune response in COVID-19 patients of varying age. We discovered highly expanded T and B cells in multiple patients, with the most expanded clonotypes coming from the effector CD8+ T cell population. Highly expanded CD8+ and CD4+ T cell clones show elevated markers of cytotoxicity (CD8: PRF1, GZMH, GNLY; CD4: GZMA), whereas clonally expanded B cells show markers of transition into the plasma cell state and activation across patients. By comparing young and old convalescent COVID-19 patients (mean ages = 31 and 66.8 years, respectively), we found that clonally expanded B cells in young patients were predominantly of the IgA isotype and their BCRs had incurred higher levels of somatic hypermutation than elderly patients. In conclusion, our scSeq analysis defines the adaptive immune repertoire and transcriptome in convalescent COVID-19 patients and shows important age-related differences implicated in immunity against SARS-CoV-2.
    Keywords covid19
    Language English
    Publishing date 2021-02-15
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2021.02.12.430907
    Database COVID19

    Kategorien

  10. Article ; Online: SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display.

    Ehling, Roy A / Weber, Cédric R / Mason, Derek M / Friedensohn, Simon / Wagner, Bastian / Bieberich, Florian / Kapetanovic, Edo / Vazquez-Lombardi, Rodrigo / Di Roberto, Raphaël B / Hong, Kai-Lin / Wagner, Camille / Pataia, Michele / Overath, Max D / Sheward, Daniel J / Murrell, Ben / Yermanos, Alexander / Cuny, Andreas P / Savic, Miodrag / Rudolf, Fabian /
    Reddy, Sai T

    Cell reports

    2021  Volume 38, Issue 3, Page(s) 110242

    Abstract: Characterization of COVID-19 antibodies has largely focused on memory B cells; however, it is the antibody-secreting plasma cells that are directly responsible for the production of serum antibodies, which play a critical role in resolving SARS-CoV-2 ... ...

    Abstract Characterization of COVID-19 antibodies has largely focused on memory B cells; however, it is the antibody-secreting plasma cells that are directly responsible for the production of serum antibodies, which play a critical role in resolving SARS-CoV-2 infection. Little is known about the specificity of plasma cells, largely because plasma cells lack surface antibody expression, thereby complicating their screening. Here, we describe a technology pipeline that integrates single-cell antibody repertoire sequencing and mammalian display to interrogate the specificity of plasma cells from 16 convalescent patients. Single-cell sequencing allows us to profile antibody repertoire features and identify expanded clonal lineages. Mammalian display screening is used to reveal that 43 antibodies (of 132 candidates) derived from expanded plasma cell lineages are specific to SARS-CoV-2 antigens, including antibodies with high affinity to the SARS-CoV-2 receptor-binding domain (RBD) that exhibit potent neutralization and broad binding to the RBD of SARS-CoV-2 variants (of concern/interest).
    MeSH term(s) Animals ; Antibodies, Neutralizing/isolation & purification ; Antibodies, Viral/isolation & purification ; COVID-19/immunology ; COVID-19/prevention & control ; Cells, Cultured ; Cohort Studies ; Gene Library ; HEK293 Cells ; High-Throughput Nucleotide Sequencing/methods ; Humans ; Mammals ; Neutralization Tests ; Peptide Library ; Plasma Cells/chemistry ; Plasma Cells/metabolism ; SARS-CoV-2/immunology ; Single-Cell Analysis/methods
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; Peptide Library
    Language English
    Publishing date 2021-12-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2021.110242
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top